Stanford University
Showing 3,041-3,060 of 34,929 Results
-
Bernardo Bonilauri
Instructor, Cardiovascular Institute
BioDr. Bernardo Bonilauri is a molecular biologist investigating the fundamental mechanisms of protein misfolding, cryptic peptides, and non-canonical codes in human biology and disease. He completed his postdoctoral training at the Stanford Cardiovascular Institute under the mentorship of Dr. Joseph C. Wu, after which he was appointed Instructor. In this role, he continues to develop advanced in vitro disease models to probe molecular and cellular processes underlying human pathology.
His research focuses on Transthyretin Amyloidosis (ATTR) and related protein misfolding disorders, applying multi-omics, structural biology, and stem cell–based platforms to dissect how pathogenic aggregates form and impair cellular function. In parallel, Dr. Bonilauri investigates microproteins encoded by small open reading frames (sORFs), with emphasis on their translation, subcellular localization, and biological functions in human cells. -
Hector Fabio Bonilla
Clinical Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Olivier N. Bonin
Digital Media Specialist 3, Strategic Communications & External Affairs
BioBorn in the French Alps, I did a Master in Electrical and Micro-Electronic Engineering. I was an engineer in the Silicon Valley for 10 years developing semiconductor libraries of components for use on chips by many of the big names in the industry. After the last company I worked with was sold in parts, I left the industry to work on a full feature documentary about Burning Man. The film, Dust & Illusions, focused on a 30-year history that surprisingly nobody ever explored before. That lead me to develop video content for various companies, such as Whole Foods, Samsung, Stanford until I joined WildAid for a year producing videos to help stop the illegal wildlife trade (that potentially led to the covid-19 pandemic). Finally today I am the video and multimedia producer for SLAC National Accelerator Laboratory with the goal of bringing attention to the fundamental research in physics and biology that the Lab focuses on.
-
Anna Booman
Member, Maternal & Child Health Research Institute (MCHRI)
BioAnna Booman, PhD, MS is a Postdoctoral Scholar in the Department of Anesthesiology, Perioperative, and Pain Medicine. She conducts perinatal pharmacoepidemiology research to study the safety and effectiveness of medication use during pregnancy, since most pregnant individuals cannot be included in clinical trials. She uses large observational datasets, such as the Merative MarketScan Database, and complex epidemiologic methods in her research.
Dr. Booman received her PhD in Epidemiology from the Oregon Health & Science University School of Public Health, her MS in Computational Biology and Quantitative Genetics from the Harvard T.H. Chan School of Public Health, and her BS in Mathematical Biology (minor: Computer Science) from the College of William & Mary. Her research has spanned many areas of perinatal epidemiology, including a focus on twin children, rare genetic disorders, gestational weight gain, and insurance discontinuity in pregnancy.
